SCI Pharmtech Inc banner
S

SCI Pharmtech Inc
TWSE:4119

Watchlist Manager
SCI Pharmtech Inc
TWSE:4119
Watchlist
Price: 50.4 TWD -0.79% Market Closed
Market Cap: NT$6B

Profitability Summary

SCI Pharmtech Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
SCI Pharmtech Inc

Margins Comparison
SCI Pharmtech Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
SCI Pharmtech Inc
TWSE:4119
6B TWD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
871.6B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.1B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
229B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296.9B USD
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.8B CHF
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
UK
GSK plc
XETRA:GS71
99.8B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
SCI Pharmtech Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
SCI Pharmtech Inc
TWSE:4119
6B TWD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
871.6B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
578.1B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
248.4B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
229B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
296.9B USD
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
230.8B CHF
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
244.4B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
154.1B USD
Loading...
Loading...
Loading...
Loading...
UK
GSK plc
XETRA:GS71
99.8B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
SCI Pharmtech Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett